Evidence map›Paper›PMID 38771861›Full record

ArticlePLoS neglected tropical diseases2024

Eosinophils, basophils and myeloid-derived suppressor cells in chronic Loa loa infection and its treatment in an endemic setting.

Gerrit Burger, Rafiou Adamou, Ruth Kreuzmair, Wilfrid Ndzebe Ndoumba, Dorothea Ekoka Mbassi, Anne Marie Nkoma Mouima, Carole Mamgno Tabopda, Roukoyath Moyoriola Adegnika, Ayong More, Dearie Glory Okwu and 10 more

Abstract read
In one paragraph

Article in PLoS neglected tropical diseases, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors.

Gerrit BurgerCentre de Recherches Médicales de Lambaréné (CERMEL), Lambaréné, Gabon.ORCID 0000-0002-0142-5284
Rafiou AdamouCentre de Recherches Médicales de Lambaréné (CERMEL), Lambaréné, Gabon.
Ruth KreuzmairCentre de Recherches Médicales de Lambaréné (CERMEL), Lambaréné, Gabon.
Wilfrid Ndzebe NdoumbaCentre de Recherches Médicales de Lambaréné (CERMEL), Lambaréné, Gabon.
Dorothea Ekoka MbassiCentre de Recherches Médicales de Lambaréné (CERMEL), Lambaréné, Gabon.
Anne Marie Nkoma MouimaCentre de Recherches Médicales de Lambaréné (CERMEL), Lambaréné, Gabon.
Carole Mamgno TabopdaCentre de Recherches Médicales de Lambaréné (CERMEL), Lambaréné, Gabon.
Roukoyath Moyoriola AdegnikaCentre de Recherches Médicales de Lambaréné (CERMEL), Lambaréné, Gabon.
Ayong MoreCentre de Recherches Médicales de Lambaréné (CERMEL), Lambaréné, Gabon.
Dearie Glory OkwuCentre de Recherches Médicales de Lambaréné (CERMEL), Lambaréné, Gabon.
Lia-Betty Dimessa MbadingaCentre de Recherches Médicales de Lambaréné (CERMEL), Lambaréné, Gabon.
Carlos Lamsfus CalleInstitute of Tropical Medicine, University of Tübingen, Tübingen, Germany.
Luzia VeletzkyCentre de Recherches Médicales de Lambaréné (CERMEL), Lambaréné, Gabon.
Wolfram Gottfried MetzgerDepartment of Internal Medicine IV, University of Tübingen, Tübingen, Germany.
Benjamin MordmüllerCentre de Recherches Médicales de Lambaréné (CERMEL), Lambaréné, Gabon.
Michael RamharterCentre de Recherches Médicales de Lambaréné (CERMEL), Lambaréné, Gabon.
Ghyslain Mombo-NgomaCentre de Recherches Médicales de Lambaréné (CERMEL), Lambaréné, Gabon.
Ayola Akim AdegnikaCentre de Recherches Médicales de Lambaréné (CERMEL), Lambaréné, Gabon.
Rella Zoleko-ManegoCentre de Recherches Médicales de Lambaréné (CERMEL), Lambaréné, Gabon.
Matthew B B McCallCentre de Recherches Médicales de Lambaréné (CERMEL), Lambaréné, Gabon.

Funding

Developing Countries Clinical Trials Partnership 2 programmeFederal Ministry of Science, Research and Economy of AustriaGerman Research Foundation (DFG)Open Access Publishing Fund of the University of Tübingen
6 · The paper itself

Abstract

backgroundChronic infection by Loa loa remains an unsolved immunological paradox. Despite harboring subcutaneously migrating adult worms and often high densities of microfilariae, most patients experience only relatively mild symptoms, yet microfilaricidal treatment can trigger life-threatening inflammation. Here, we investigated innate cell populations hypothesized to play a role in these two faces of the disease, in an endemic population in Gabon. METHODOLOGY/PRINCIPAL

findingsWe analyzed numbers and activation of eosinophils and basophils, as well as myeloid-derived suppressor cell (MDSC) subsets and associated circulating cytokine levels by flow cytometry in sex- and age-matched L. loa-uninfected (LL-), -amicrofilaraemic (MF-) and -microfilaraemic (MF+) individuals (n = 42), as well as microfilaraemic individuals treated with albendazole (n = 26). The percentage of eosinophils was lower in LL- (3.0%) than in the combined L. loa-infected population, but was similar in MF+ (13.1%) and MF- (12.3%). Upon treatment of MF+, eosinophilia increased from day 0 (17.2%) to day 14 (24.8%) and had decreased below baseline at day 168 (6.3%). Expression of the eosinophil activation marker CD123 followed the same pattern as the percentage of eosinophils, while the inverse was observed for CD193 and to some extent CD125. Circulating IL-5 levels after treatment followed the same pattern as eosinophil dynamics. Basophil numbers did not differ between infection states but increased after treatment of MF+. We did not observe differences in MDSC numbers between infection states or upon treatment. CONCLUSIONS/SIGNIFICANCE: We demonstrate that both chronic infection and treatment of L. loa microfilaraemia are associated with eosinophil circulation and distinct phenotypical activation markers that might contribute to inflammatory pathways in this setting. In this first ever investigation into MDSC in L. loa infection, we found no evidence for their increased presence in chronic loiasis, suggesting that immunomodulation by L. loa is induced through other pathways.

Indexed as

BasophilsEosinophilsLoaLoiasisMyeloid-Derived Suppressor CellsAdolescentAdultAlbendazoleAnimalsChronic DiseaseCytokinesEndemic DiseasesFemaleFlow CytometryGabonHumansAlbendazoleCytokines

Identifiers

PMID38771861
PMCPMC11147522

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.